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current methods to isolate rare (1:10,000-1:100,000) bacterial artificial chromosome (BAc) recombinants require selectable markers. For seamless BAc mutagenesis, selectable markers need to be removed after isolation of recombinants through counterselection. here we illustrate founder principle-driven enrichment (FPe), a simple method to rapidly isolate rare recombinants without using selectable markers, allowing one-step seamless BAc mutagenesis. As proof of principle, we isolated 1:100,000 seamless fluorescent protein-modified Nodal BAcs and confirmed BAc functionality by generating fluorescent reporter mice. We also isolated small indel P1 phage-derived artificial chromosome (PAc) and BAc recombinants. statistical analysis revealed that 1:100,000 recombinants can be isolated with <40 Pcrs, and we developed a web-based calculator to optimize FPe.
Recombination-mediated genetic engineering (recombineering) is a technique to manipulate DNA in Escherichia coli using short homology sequences [1] [2] [3] . BAC recombineering allows the study of gene expression and function 4 , but it needs to be seamless to avoid any unnecessary sequence in modified BACs. Currently, seamless mutagenesis requires two steps: isolation of mutants using selectable markers followed by marker removal through counterselection 5 (Fig. 1) . This approach has substantial drawbacks because counterselection is relatively complex, prone to false positives, and resource and time consuming 6 .
Single-stranded oligonucleotide targeting vectors can produce seamless single-base alterations, deletions and short insertions in BACs. Occasionally, these changes can occur at such high frequencies (1:90-1:260, up to 70%) that recombinants can be isolated without selection 7, 8 . However, these frequencies are not routinely achieved 9 , and some DNA inserts, such as those encoding fluorescent protein reporters 10 , are too large to be encompassed in commercially available oligonucleotides. Seamless fluorescent reporters are less likely to interfere with regulatory elements, isolation of rare recombinants without using selectable markers for one-step seamless BAc mutagenesis including those located in introns as is the case for Nodal 11 , a critical developmental gene belonging to TGF-β superfamily 12 . The recombination frequency for large inserts can be between one recombinant BAC per 10,000-100,000 electroporated cells. Current laboratory methods do not allow isolation of these rare recombinants without using selection. Techniques such as clone pooling or cloning by limiting dilution 13 can be used for isolating only high-frequency (1:90-1:260) recombinants 8 .
In population genetics, the founder principle is defined as "the establishment of a new population by a few original founders." 14 In small populations, the proportional decrease of parental alleles is disrupted, resulting in the random elimination or fixation of some alleles 15 . Applying this principle to recombineering, we reasoned that sampling a number of cells below a certain threshold from an E. coli parental culture disrupts the proportional decrease of rare recombinant and prevailing nonrecombinant BACs. This threshold is the reciprocal of the frequency of recombinant BACs in the parental culture. Under these conditions, we can establish founder cultures with either no recombinants or a higher frequency of recombinants, i.e., enrichment, which can be detected by PCR.
Applying these notions, we developed FPE, a simple, low-cost and efficient method to isolate rare BAC recombinants without using selectable markers. We isolated seamless fluorescent protein-modified Nodal BACs and confirmed their functionality by generating reporter mice. We also successfully used FPE to isolate small indel PAC and BAC recombinants, and we optimized FPE through statistical modeling. results isolation of rare modified Nodal BAcs using FPe Using markerless targeting vectors (Supplementary Fig. 1 ), we generated rare mutant BACs in which the first exon downstream of the Nodal start methionine was partially replaced by mStrawberry or EYFP (Online Methods). To estimate the recombinant frequency (f) in recombineering mixes and establish FPE parental cultures, we dispensed 10 5 total cells per well in a single 96-well plate ( Fig. 2 and Supplementary Fig. 2 ). In this plate, PCR detected recombinant-containing wells, identifying positive parental saturated cultures (SCs).
To start enrichment cycles, we diluted positive SCs to establish a diluted culture (DC) containing 10 5 total cells and, presumably, at least one recombinant ( Fig. 2 and Supplementary Figs. 2  and 3 ). 10 5 cells is the FPE threshold for a recombinant frequency of 10 −5 . Then we equally divided the DC in a single 96-well plate to establish founder cultures-that is, diluted and divided cultures (DDCs)-with ~1,000 total cells, i.e., 100 times below the FPE threshold. After overnight growth, positive SCs were again identified by PCR. The frequency of mutant BACs in PCR-positive wells was at least 1:1,000 (10 −3 ).
FPE was again performed on positive cultures, and at the end of the second cycle, the frequency of mutant BACs was increased to ~10 −1 ( Supplementary Fig. 4 ). At this point, ~20-30 PCRs were needed to detect a mutant BAC clone by screening individual colonies on agar plates. Alternatively, a similar number of PCRs was needed for the third enrichment cycle to reach f of ~1/1. The first approach was used to isolate mStrawberry, and the second one for EYFP, with two or three FPE cycles being completed in about 2-4 d. These data show that FPE enables the isolation of mutant BACs as rare as 1:100,000 without using selectable markers.
Applicability of FPe
In genetic engineering, it is often necessary to insert or delete loxP and FRT sites on/from BAC vector backbones or cloned inserts 16 . Thus, we tested whether FPE can isolate PAC and BAC recombinants generated by single-stranded oligonucleotide-directed recombineering. We started with a mini-P1 phage vector derived from pCYPAC3 (ref. 17) in which a fragment of plasmid PL253 (ref. 18 ) with a 20-nucleotide repeat replaced the mini-P1 phage vector sequence containing loxP and I-SceI. We deleted the 20-nucleotide repeat and reinserted loxP and I-SceI in different sites of the vector, using FPE to isolate seamless PAC recombinants (Supplementary Table 1) .
To test FPE in BACs, we deleted vector backbone loxP from nine distinct BACs and then isolated recombinant clones using FPE (Supplementary Table 2) . Notably, eight BACs were simultaneously isolated by one person. Finally, we inserted a 74-nucleotide array consisting of FRT, loxP and a restriction endonuclease recognition site into the cloned DNA of three BACs modified in the previous step, which was followed by their rapid isolation via FPE (Supplementary Table 2 ). At the reported electroporation and recombineering efficiencies, the recombination frequency in these insertion experiments ranged from 3 × 10 −2 to 6 × 10 −5 (1:30-1:17,000). In all cases, FPE successfully isolated PAC and BAC recombinants and their structure was confirmed by DNA sequencing.
In a few instances we had to perform additional enrichment cycles to isolate recombinants. This did not alter the overall success of FPE. To determine whether the need for additional enrichment cycles could be due to differential growth of recombinants versus wild types, we reconstituted cell mixes with known frequencies of EYFP-mutant BACs ( Supplementary  Fig. 5 ). We reisolated recombinant BACs from these mixes without observing any deviation from the expectations of our FPE model. Additionally, there was overlap of the confidence intervals between the DDC and SC recombinant frequencies Supplementary Fig. 6 ), and we observed similar growth rates in cells harboring recombinant and nonrecombinant BACs (Supplementary Fig. 7 ). Thus, we speculate that the occasional need to perform additional enrichment cycles could be due to instability of some newly generated recombinants. This is consistent with a report showing that integration of a chloramphenicol marker into lacZ can generate both white (Lac − ) and unstable, blue (Lac + ) chloramphenicolresistant colonies 19 . Overall, these data show that FPE can isolate PAC and BAC indels within a relatively broad range of frequencies and in a variety of DNA engineering strategies.
testing the functionality of modified Nodal BAcs
To confirm functional integrity of modified BACs, we generated fluorescent reporter Nodal mice. The mStrawberry and EYFP Nodal BACs were purified and sequenced to ensure generation of correct structures (Online Methods). However, because recombineering can generate repeats 19 , deletions 6 and plasmid concatenates 20 , there could be structural modifications elsewhere in the BAC leading to altered expression of the reporter. Thus, we used the modified BACs isolated via FPE to generate transgenic reporter mice and found that mStrawberry and EYFP recapitulate the endogenous Nodal expression at embryonic day 6.5 (e6.5) (Fig. 3) . These experiments show that seamless fluorescent protein-modified Nodal BACs generated without selectioncounterselection have the correct structure and function.
computational modeling of FPe
We built a mathematical model to elucidate some FPE features, such as the inclusion of multiple cycles and how to manage the risk of failure. FPE has three parameters: r, the enrichment rate; a, the dilution number; and b, the division number (Online Methods and Supplementary Note), with any two of them being independent. As shown in equation (7) (Supplementary Note), any recombinant frequency could be obtained in one enrichment cycle by properly selecting the product a × b. However, because b was equal to the number of DDCs to be screened by PCR, there was a practical limit of divisions (B) that an operator could perform in a day. In addition, attempting higher enrichment by overly increasing a could produce DCs with a low probability of containing mutants. Thus, a was also limited. With both a and b limited, their product was often not high enough to achieve the desired recombinant frequency in one cycle, showing that FPE needs to be performed in repetitive cycles. The number of cells containing mutant BACs followed a binomial distribution in both DCs and DDCs (Supplementary Note). This allowed for calculating the risk of failure (Supplementary Note, equation (16)), which can be managed by changing b/r, that is, the average number of recombinants sampled in DCs (Online Methods). We derived formulas for the expected number of cycles, and hence number of PCRs to complete FPE, for any given risk of failure (Supplementary Note, equation (18)).
optimizing FPe for high-throughput applications
To make FPE suitable for high-throughput applications, we optimized it by building an FPE cost function. Optimal FPE parameters minimize the relative expense of resources (number of PCRs), α, and time (number of cycles), 1 − α. From equation (21) (Supplementary Note), the cost function equaled the mean number of cycles to complete FPE when α = 0 (time-saving strategy) (Supplementary Note, equation (19)) and the mean number of PCRs to complete FPE when α = 1 (resource-saving strategy). At intermediate numbers, i.e., 0 < α < 1, the cost function was the sum of the expected number of cycles and PCRs multiplied by 1 − α and α, respectively.
When time-saving was a priority, α = 0, the cost function decreased with increasing b (Fig. 4a) . When b reached its practical limit B, there was an optimal enrichment rate minimizing the cost function. When B = 100, the V-shaped cost function curve indicated that sampling two to three recombinants in DCs at each cycle (b/r = 100/~45 = 2-3) was highly advantageous (Fig. 4a) . To a lesser degree, this was true for other B values up to 400. Thus, when an investigator can perform 100-400 PCRs per day, the optimal scenario is sampling two or three recombinant BACcontaining cells in DCs at each cycle.
When resource-saving was a priority, α = 1, minimization of the cost function was reached at r min = exp(1) = e ≈ 2.72 (see Supplementary Note, equation (22)) regardless of b, implying that the enrichment rate was constant (~2.72) at any division number, b. For example, to increase mutant BAC f from 10 −5 to 10 −1 using the minimal number of PCRs, the expected number of cycles when sampling one mutant BAC-containing cell in DCs was 14.62 (9.21/(1 -0.37)) and was 9.69 (9.21/(1 -0.05)) when sampling three mutants (Supplementary Note, equation (18), in which 9.21 is calculated using equation (10)). The expected minimal number of PCRs was 2.72 × 1 × 14.62 = 39.77 and 2.72 × 3 × 9.69 = 79.07, respectively. Thus, the number of PCRs could be as low as ~40 for isolating 1:100,000 mutant BACs.
We optimized the cost function for any given α because both time and resources are important for high-throughput applications (0 < α < 1). For this interval, there was a unique pair of FPE parameters (b min (α), r min (α)) that minimized the cost function (Fig. 4b,c) . As expected, with α closer to 0, i.e., the time-saving strategy, FPE optimization led to increasing the division number b; with α closer to 1, i.e., the resource-saving strategy, it led to an enrichment rate r approaching e (~2.72) (Fig. 4b,c) . To facilitate determination of the optimal FPE parameters in any working condition, we developed a web calculator (http://yost. genetics.utah.edu/software.php#FPE_Calculator/; also available discussion FPE has a number of important features. First, bacterial cultures at consecutive enrichment cycles are established and grown in such a way that the frequency of recombinants progressively increases in a controllable and predictable manner. Second, screening is done on replicas so that the culture never contacts the reagents or factors used for screening 21 . This avoids any disturbance on cell metabolism, and isolated recombinants retain the genuine structures generated by recombineering. Third, FPE does not result in false positives because PCR can be designed to detect the expected recombineering product. Finally, FPE per se is a liquid-dispensing procedure that can be easily robotized.
The isolation of unselected recombinants is a classical problem in recombinant DNA technology 2, 22, 23 . The classical solution has been to link a recombining DNA sequence of interest to selectable markers. We and others have shown that not only does selection increase the amount of engineering work, it can also change the rate of genetic variants 24, 25 . In addition, even with recent improvements in selection-counterselection, seamless BAC recombineering still requires two targeting vectors, 5 d for each recombineering step and counterselection using numerous reagents 6 . Instead, FPE can achieve the same goal in 5 d using only the second of the two targeting vectors (Fig. 1) .
Our statistical analysis suggests that FPE can substantially improve genome-wide recombineering pipelines. Using selection markers in recombineering pipelines for functional genomics leads to the persistence of some unnecessary DNA sequences, which can disrupt normal gene function. Additionally, selection in liquid cultures produces cell mixes containing up to hundreds of independent recombinants 4, [26] [27] [28] [29] [30] [31] . This leads to the need to isolate clones, a step that is currently extremely time consuming 29 . In contrast, FPE enriches cultures with seamless recombinants originating from the same, single recombinant event. Barcoded genetic variant pipelines have proven invaluable for multiplex reverse genetic studies 26, 30 , but they remain time consuming. For example, for barcoding functional open reading frames in yeast, two unique PCR products are generated for each open reading frame, after which these products are joined with a cloning vector in vivo 32 . Similar work in E. coli could be performed by directly introducing barcodes in vivo through one-step seamless recombineering followed by rapid recombinant isolation through FPE. FPE could also improve multiplex automated genome engineering (MAGE), a pipeline used to improve bacterial phenotypes through accelerated evolution 33 . MAGE generates an enormous degree of genetic diversity, but it lacks a procedure for sifting out genetic variants that have no effect on or that worsen the phenotype. Alternating cycles of MAGE with FPE might accelerate the generation of improved bacterial phenotypes. Finally, FPE could be used to isolate any rare genetic variant identifiable in culture with a properly selected screening assay. For example, it could be applied to breed transgenic plants with desired traits without drug and pesticide resistance markers 34 .
This work demonstrates that rare BAC recombinants can be isolated without using selectable markers, representing a valid alternative to the classical selection method. Because of its rigorous mathematical basis and statistical optimization, FPE can online methods Chemicals and enzymes. Chemicals were purchased from SigmaAldrich or Mallinckrodt Baker. All enzymes were purchased from New England BioLabs, except the following polymerases: ampliTaq (Life Technologies), PerfectTaq (5 PRIME) and KOD (Clontech Laboratories).
Plasmids. Wild-type Nodal BAC, 204-kb RP23-450D10 BAC clone (http://bacpac.chori.org/) and BACs reported in Supplementary Table 2 were used. Plasmids containing the coding sequences of mStrawberry and EYFP were received from V. Boyko (National Cancer Institute).
Plasmid DNA isolation and purification. Plasmid DNA was extracted as previously described 35 , but the composition of the non-ionic detergent (NID) isolation buffer was improved to promote bacterial debris pelleting and reduce insoluble components in DNA solution. The new formulation is as follows: 0.75 M NH 4 Cl, 0.25 M Tris-HCl, pH 9, 5 mM EDTA and 0.15% (v/v) IGEPAL CA-630. E. coli chromosomal DNA and endotoxins were removed as previously described 36 . Purified BAC DNA was linearized by PI-SceI homing endonuclease digestion of the pBACe3.6 vector backbone. Linearized DNA was purified using anion-exchange plasmid mini kit columns (121123; Qiagen). DNA sequencing. DNA sequencing was performed using the ABI BigDye Terminator Cycle Sequencing Kit v1.1 or v3.1 according to the manufacturer's instructions on a Gene Amp 9700 PCR machine. The sequence fragments were detected on an ABI 3130XL Genetic Analyzer. Samples were then analyzed and base called using the Applied Biosystems DNA Sequencing Analysis Software V5.2. The following primers were used to confirm the structures of the break points: 5′BP:f_Nodal_10317: CGC CCT CTT CTG GAG TGT CTG A; 3′BP:r_Nodal_11870: GCA TCA CTC AGG TCG CTG GGT CAA ACA CA. For recombinants generated by single-stranded oligonucleotide-directed recombineering, the primers used for detecting recombinants were also used to confirm the expected breakpoint structure (see "Oligonucleotides" below). Primers for the fluorescent protein-coding sequences were f_Str_588: CGC CTA CAT CGT CGG CAT CAA GTT; r_Str_145: CGG TCT GGG TGC CCT CGT A; f_YFP/Str_1: ATG GTG AGC AAG GGC GAG GA; and f_YFP_411: CCT GGG GCA CAA GCT GGA GTA CAA CTA. There was no need to use additional primers for sequencing recombinants generated by single-stranded oligonucleotide-directed recombineering because the modifications encompassed short DNA sequences.
Recombineering. Mini-λ was provided by S.K. Sharan (National Cancer Institute). Electro-and recombineering-competent DH10B cells harboring wild-type Nodal BAC were prepared as described previously 37 . 0.1-0.3 µg targeting vector DNA was electroporated at 16,000-18,000 V/cm at time constants of 7.5-10 ms using Bio-Rad Gene Pulser II or Bio-Rad GenePulser Excell into 20-40 µl competent cells.
Oligonucleotides. All oligonucleotides were desalted and ordered from Invitrogen (Life Technologies), except the primers with IDs #11 and #12, which were PAAG purified and ordered from IDT. Except for oligonucleotides used in DNA sequencing (see above), all sequences are reported (Supplementary Table 3) . mStrawberry and EYFP targeting vectors replaced 168-bp Nodal exon1 sequence chr10: 61418300-61418467 (NC_000076.6), with the fluorescent protein coding sequences leaving the last 28 bp of the exon.
PCR.
Mixing bacterial cultures by pipetting up and down and sampling bacteria from 96-well plates were done using 12-channel pipettes (manufactured by Capp or Eppendorf). PCR of bacterial cultures: 0.7-1 µl of every bacterial culture was transferred into 96-well PCR plates containing 10 µl PCR mix of 1× PCR buffer; 0.2-0.3 µM primers; 0.2 mM dNTP; 0.2 mg/ml BSA (optional); and 20 U/ml AmpliTaq or PerfectTaq. 5× PCR buffer composition was 100 mM Tris-HCl, pH 8.8, 50 mM (NH 4 ) 2 SO 4 , 15 mM MgSO 4 , 0.5% (v/v) Triton X-100, 0.25% (v/v) Tween 20, and 50% (v/v) glycerol. Addition of tracking dyes to the PCR buffer, such as 0.001% (w/v) xylene cyanol, allows direct gel loading of PCR mixtures. The PCR program had a 4-min first hold at 94 °C to lyse bacteria and denature DNA, 10-15 s for annealing primers at temperatures between 55 and 62 °C, and times for primer extension calculated according to a rate of 500 bp/min. The program consisted of 30-45 cycles. The PCR assay was able to detect up to one recombinant per 1,000,000 total cells (Supplementary Fig. 5 ). Gels were loaded using multichannel Impact 2 Matrix pipettes (Thermo Scientific). Targeting vector DNA PCR was performed using KOD or Phusion polymerases and linearized plasmids containing the coding sequences of the fluorescent proteins according to the manufacturers' instructions. PCR products were treated consecutively with DpnI and mung bean nuclease and then purified using agarose gel electrophoresis. The following supplies were used: EU PCR Plate, 96 × 0.2 ml, non-skirted (Bioplastics, from MidSci, cat. B70504-CL); reusable Corning Thermowell sealing mats (cat. 6555); 10 mM dNTPs from GenScript (C01582-10); and PerfectTaq DNA Polymerase from 5 PRIME (cat. 2200070). The expected cost of major consumables for about 1,000 PCRs (10 µl) was ten 96-well PCR plates ($11) + dNTPs ($3.1) + Taq polymerase ($11) ≈ $25.
Establishing parental E. coli cultures. The recombineering cell mix contained ~10 9 cells. A fraction of the recombineering mix containing ~10 7 cells was mixed with an appropriate volume of growth medium so that ~10 5 total DC cells were dispensed into each well of a 96-well cell culture or PCR plates in 12-to 100-µl aliquots. The LB/Super Broth (1:1) medium contained 0.4% glucose, 5 mM MgSO 4 and 12-15 µg/ml chloramphenicol. The plates were incubated in a PCR machine (for bacteria dispensed in PCR plates) or in an incubator (for bacteria dispensed in 96-well cell culture plates and incubated in moisture-tight containers) at 30-37 °C overnight. Both repetitive (Distriman, Gilson) and multichannel pipettes were used for liquid sampling/dispensing. It was not necessary to outgrow cells before plating owing to lack of drug selection in recombinants, but chloramphenicol was added to retain wild-type and recombinant BACs in cells. In general, the number of parental cultures in one plate was more than enough to isolate at least one recombinant because there were some positive parental cultures (Supplementary Figs. 8 and 9) . If no positive parental cultures are detected, cultures can be reestablished with greater amounts of the recombineering mix. The saturated parental cultures were also kept as an independent npg source of recombinants in case of problems during subsequent steps. As trial-and-error experiments might be needed to estimate the frequency of recombinants in the recombineering mix, a 10% glycerol stock was prepared from the rest of the recombineering mix for later use. A 30-min outgrowth of the recombineering mix improved the survival of frozen cells after thawing.
Before starting screening parental cultures for recombinants, we electroporated control targeting vector DNA to ensure that recombineering has taken place. For selection-based controls (Supplementary Table 2) , the DNA produces colony-forming units (CFUs) only in recombineering competent cells; for counterselection-based controls (Supplementary Table 1) , the DNA produces 2-3 orders more CFUs in recombineering competent cells compared to the background CFUs. For example, for PCR with primer IDs #3 and #4, pUC series plasmid DNA generated about 1 kb of DNA targeting vector with 30-nucleotide homology arms to the BAC vector backbone at its flanks. The targeting vector incorporated the Amp r marker from the plasmid, and upon recombination with the BAC vector backbone, the cells lose resistance to chloramphenicol but acquire resistance to ampicillin. The DpnI-treated targeting vector DNA is free of replicative plasmid DNA template contamination and should not produce Amp r cells when electroporated in DH10B cells with an electroporation efficiency of about 5 × 10 9 CFU per microgram pUC18. The number of drug-resistant colonies in the positive control could also be used for estimating the number of positive parental cultures when plating the recombineering mix.
Computation of binomial confidence intervals. To determine whether recombinant cells differ in growth rate from nonrecombinant cells, we calculated the confidence intervals of the frequency of recombinants for 15 different constructs both before (in DDC) and after overnight growth (in SC) (Supplementary Tables 1 and 2 and Supplementary Fig. 6 ). In all 15 cases, confidence intervals overlap broadly, which is consistent with our hypothesis that recombinant genotype does not affect growth rate. Because our predicted effect size was 0, we did not perform a power analysis. We chose instead to rely upon overlapping confidence intervals to illustrate the negative results. Binomial confidence intervals were calculated using the Clopper-Pearson exact method as implemented in R (ref. 38 ; http://www.r-project.org/) by the "binom" package (http://CRAN.R-project.org/package=binom). This method assumes only that the data are binomially distributed, an assumption that is well justified given that we have counts of bacterial colonies where each is assessed for a binary outcome (recombinant vs. nonrecombinant). Equal variance is not an assumption of the Clopper-Pearson method. Variance for each construct is not explicitly estimated but is well illustrated by the confidence intervals.
The basics of FPE. There are two FPE prerequisites. The first one is to retain at least one recombinant in a culture with reduced size. The second prerequisite is that the size of this culture should be below the FPE threshold. These prerequisites allow the recombinant frequency to increase in each successive enrichment cycle (Fig. 2) .
With f i being the recombinant frequency in the current cycle and f i+1 the one in the next cycle, a specific enrichment rate, r, defined as f i+1 /f i , can be reached by diluting (a) and dividing (b) the culture in the following way. To sample any (n) number of recombinants on average per ml (n/ml) into a DC from a PCR-positive SC with a given number of total cells per ml (N/ml) and a recombinant frequency (f), SC should be diluted a = N × f/n. Dividing 1 ml DC containing n recombinants n × r times will reduce the total cell number of cells in DDCs to N/(N × f/n)/n × r = 1/f × r, which is r times less than the FPE threshold. The positive DDCs most likely have one recombinant among 1/f × r totals and the recombinant frequency in the next cycle is 1/1/f × r = f × r. Thus, to establish positive DDCs enriched r times for recombinants, 1 ml DC containing n recombinants should be equally divided b = n × r. It follows that b/r = n, where n is the number of recombinants in DC.
FPE has the interesting feature of being more efficient at low recombinant frequencies. Since f i+1 = 1/N i+1 , the enrichment rate r is equal to 1/f i × N i+1 , showing that in order to enrich cultures, the denominator f i × N i+1 should be less than 1. This implies that when f i is low, the total number of cells N i+1 in DDCs can be high, requiring less effort to divide and dilute SC. Thus, FPE is more efficient at lower recombinant frequencies.
For the implementation of FPE, the following values need to be known: (i) f, (ii) N/ml in SC and (iii) r. In positive SCs, f is estimated as the reciprocal of the number of CFUs per DDC. N/ml, i.e., SC total cell titer, is determined as CFU number per ml in SCs. This can be determined experimentally before starting the next enrichment cycle (spending one more day), or the currently known total cell titer can be used. We found that with the culture medium used in our laboratory, N has consistently been ~1-3 × 10 9 CFUs/ml, and the experimental determination of exact N does not enrich cultures more efficiently than using an estimated number of 1 × 10 9 -2 × 10 9 for all enrichment cycles. Selecting r is connected to selecting b and depends on whether FPE is designed to be time and/or reagent saving (see "Computational modeling of FPE" in Results), but b cannot be greater than the practical limit of the number of screening PCRs, B, that an operator can analyze in 1 d. In our experience, up to 400 PCRs per day are reasonable for a single operator using an electronic multichannel pipette.
At the last enrichment cycle, when N is the lowest, an alternative approach to meet the first FPE prerequisite is to use cloning by limiting dilution (LDC), i.e., establishing DDCs by dividing few differentially diluted DCs (instead of just one). See the detailed mathematical analysis of FPE in the Supplementary Note. Generation of transgenic mice. All animals (Mus musculus) were cared for and used humanely according to the following policies: The US Public Health Service Policy on Humane Care and Use of Animals (1996) ; the Guide for the Care and Use of Laboratory Animals (1996); and the US Government Principles for Utilization and Care of Vertebrate Animals Used in Testing, Research and Training (1985) . All Frederick National Laboratory for Cancer Research animal facilities and the animal program are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. All animal handling and procedures were approved by the Animal Care and Use Committee, NCI-Frederick. Purified modified BACs were diluted in the injection buffer (10 mM Tris, 0.025 mM EDTA), and 1-1.5 ng/µl DNA was microinjected into pronuclei of C57BL/6NCr zygotes, which were then transferred into pseudopregnant B6D2F1 npg
